One of the under-appreciated features of the San Diego innovation ecosystem is the increasing significance of its proximity to one of North America’s most dynamic manufacturing hubs, Baja California, and in particular, Tijuana.
In 2006 my research team at UC San Diego published a bilingual report on the potential synergies between the innovation economy on the U.S. side of the border and the increasing manufacturing capabilities, engineering, and technical skills on the Mexican side. The cluster of manufacturing expertise includes companies in Tijuana that specialize in producing medical devices, pharmaceuticals, and electronics.
MIMETAS is part of Medical Delta: the consortium of top life sciences and medical technology partners in the Netherlands. Medical Delta is a research, sales and logistics driven life sciences and medical technology cluster situated in the economic heart of the Netherlands, between Amsterdam Schiphol Airport and the Port of Rotterdam. In this Leiden — Delft — Rotterdam region, top-ranked universities and medical centers work together with industry and government to provide a dynamic environment for innovative spinoffs and international companies. With thanks to Roel Kamerling.
Richard Bendis and BioHealth Innovation were among the small businesses and individuals honored by the US Small Business Administration at the 2014 Tibbetts awards. Winners of the award have been critical in supporting the SBIR/STTR program in many different ways and are at the forefront of driving innovation. Read the full PR Newswire press release here.
The BHI SBIR/STTR Federal Funding Assistance Program offers biohealth companies support in preparing applications for federal funding inclusive of SBIRs, STTRs, and other federal government awards. Companies submit their federal funding concepts and receive pre-proposal feedback to help troubleshoot and strengthen your application. Further support from professional consultants and service providers is available to assist in improving your application.
For more information on the program, contact Ethan Byler.
BHI is pleased to announce the promotion of Amanda Wilson to the position of Director, Finance & Human Resources. Amanda joined BioHealth Innovation, Inc. two years ago as the Operations Manager.
Over the past two years, Amanda has transitioned BHI’s accounting method from cash to accrual. She has ensured BHI compliance with Generally Accepted Accounting Principles (GAAP), and has represented BHI through two successful audits. In addition, Amanda has developed human resources policies and procedures and has maintained employee access to BHI’s benefits package. Amanda recently completed her MBA at The George Washington University, and is able to augment her pre-existing skills through this degree.
Join us in congratulating Amanda on a well-deserved promotion!
– BHI offers program that guides biohealth startups in securing federal funding –
ROCKVILLE AND BALTIMORE, MARYLAND, June 10, 2014 – BioHealth Innovation, Inc. (BHI) announced today that two local biohealth companies to which it has provided strategic assistance, N5 Sensors, Inc. and BioDatomics, have secured Small Business Innovation Research (SBIR) awards. N5 Sensors, a BHI client, received two awards: one from the Enivronmental Protection Agency (EPA) and one from the National Science Foundation (NSF). BioDatomics, which participated in a federal funding assistance program offered by BHI, secured an SBIR grant from the National Institutes of Health (NIH)1. The U.S. federal government’s SBIR program encourages domestic small businesses to engage in federal research and development that has the potential for commercialization. The SBIR program empowers these companies to develop their trade and provides a path to profitability.
“BHI is dedicated to supporting start-up biohealth companies in Central Maryland in their submission of competitive SBIR applications,” said Ethan Byler, Director, Innovation Programs, BioHealth Innovation, Inc. “We congratulate N5 Sensors and BioDatomics on receiving SBIR grants from the EPA, NSF and the NIH, respectively.”
N5 Sensors of Rockville, which is developing a new generation of chemical sensors that can detect harmful chemicals mixed in air in very small quantities, recently announced that the EPA has issued a SBIR Phase I grant to the company for its low-power, small form-factor benzene sensors for exposure monitoring using mobile devices. The $100,000 grant will support N5’s work developing sensors that can detect small amounts of benzene in the air. A University of Maryland, College Park spin-off, N5 Sensors, Inc. has engaged BHI to support its commercial strategy. N5 has also recently been awarded a Phase I SBIR from the NSF to develop chip-scale carbon monoxide and ammonia sensors.
|
The Maryland Business Incubation Association (MBIA) was founded in 2002 to advance business incubation in Maryland. Representing 22 incubators, MBIA supports nearly 550 companies across the state in both urban and rural areas. Since its inception, our incubators have generated 11,800 jobs, making it equivalent to one of the state’s largest employers. Our incubators reflect the diversity of industry in the state, from biotechnology to IT. We continue to evolve to capture and grow the latest technologies that our economy generates, most recently in clean tech and cyber security. |
|
The NCIIA 19th annual conference–Open 2015–will be held March 20-21 in Washington, D.C. The conference will cover all aspects of tech entrepreneurship in higher education. Specific topics include program models, student perspectives, and entrepreneurship in low-resource settings. Call for Proposals now open: deadline 9/10.
About the Conference:
March 20-21, Washington, D.C.
NCIIA is dedicated to fostering an emerging generation of young inventors and entrepreneurs driven to improve life for people and the planet. Our Open conferences gather together engaged faculty and university students from across multiple disciplines to share stories, start new collaborations and learn best practices in technology entrepreneurship education.
FRIDAY, JUNE 13, 2014 8:00 am
Emerging Strategies for the Production and Characterization of Biosimilars
The biomanufacturing industry faces an unprecedented challenge with the emergence of biosimilars. The pathway to approval for biosimilars is a fluid process and several key aspects are still not determined. The University of Maryland and the National Institute of Standards and Technology (NIST) will deliver a one-day symposium on the current trends of characterization and production of biosimilars. On Friday, June 13, 2014 at 8:30 am join the thought-leaders, policy-makers, and creators of biosimilars as we present current trends, ideas, and predictions.
Guest Speaker: Rich Bendis, Founder, President & CEO, BioHealth Innovation, Inc.
The chair-elect of the Economic Development Committee, Leslie Weber, welcomed MCCC members and introduced the guest speaker, Rich Bendis, Founder, President & CEO, BioHealth Innovation, Inc. (BHI). BHI is an innovation intermediary that connects market relevant research assets to appropriate funding, management, and global markets to facilitate the development of commercially viable biohealth products and companies.
The organization co-founds early stage biohealth companies and works directly with existing regional commercially relevant biohealth firms on their early business development milestones to accelerate commercialization. Ninety percent of the companies BHI is working with are in Montgomery County Maryland.